Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-28 Sale |
2021-12-30 5:20 pm |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
539,283 | $2.4502 | $1,321,329 | 551,862 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-09 Option Award |
2023-03-10 7:06 pm |
N/A 2033-03-09 |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
400,000 | $0 | 400,000 (Direct) |
View |
| 2023-02-11 Tax Withholding |
2023-02-14 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
5,310 | $1.35 | 46,771 (Direct) |
View |
| 2023-02-11 Exercise |
2023-02-14 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
13,020 | $0 | 46,771 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-11 8:43 pm |
N/A 2032-03-10 |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
450,000 | $0 | 450,000 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 7:42 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
52,081 | $0 | 52,081 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:20 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
194,250 | $0.6919 | 551,862 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:20 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
79,689 | $1.14 | 551,862 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:20 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
236,899 | $2.11 | 551,862 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:20 pm |
N/A 2030-03-17 |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
510,838 | $0 | 551,862 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 5:00 pm |
N/A 2031-03-15 |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
419,500 | $0 | 419,500 (Direct) |
View |